Isis Pharmaceuticals, Inc. (ISIS) to Present at the 2013 UBS Global Healthcare Conference
5/13/2013 6:40:55 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Earns $3.5 Million From Biogen Idec, Inc. (California) (BIIB)
5/10/2013 9:32:18 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) to Present at the Bank of America (BAC) Merrill Lynch 2013 Health Care Conference
5/9/2013 11:13:51 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Prices Public Offering of Common Stock
5/9/2013 9:42:42 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Announces Proposed Public Offering of Common Stock
5/8/2013 10:03:49 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Reports Financial Results and Highlights for First Quarter 2013
5/8/2013 6:30:30 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients With Liver Cancer
5/6/2013 9:52:20 AM
More...
|
Webcast Alert: Isis Pharmaceuticals, Inc. (ISIS)' First Quarter 2013 Financial Results Conference Call
5/2/2013 11:17:18 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy
4/23/2013 9:41:26 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) to Present at the 12th Annual Needham Healthcare Conference
4/23/2013 7:25:14 AM
More...
|
|